350 related articles for article (PubMed ID: 18186077)
1. MRI in ocular drug delivery.
Li SK; Lizak MJ; Jeong EK
NMR Biomed; 2008 Nov; 21(9):941-56. PubMed ID: 18186077
[TBL] [Abstract][Full Text] [Related]
2. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Galbán CJ; Lutz RJ; Dedrick RL; Csaky KG; Lizak MJ; Wang NS; Tansey G; Robinson MR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
[TBL] [Abstract][Full Text] [Related]
3. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
4. Episcleral, intrascleral, and suprachoroidal routes of ocular drug delivery - recent research advances and patents.
Gilger BC; Mandal A; Shah S; Mitra AK
Recent Pat Drug Deliv Formul; 2014; 8(2):81-91. PubMed ID: 25001638
[TBL] [Abstract][Full Text] [Related]
5. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
Short BG
Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
[TBL] [Abstract][Full Text] [Related]
6. Periocular routes for retinal drug delivery.
Raghava S; Hammond M; Kompella UB
Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
[TBL] [Abstract][Full Text] [Related]
7. Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.
Li SK; Molokhia SA; Jeong EK
Pharm Res; 2004 Dec; 21(12):2175-84. PubMed ID: 15648248
[TBL] [Abstract][Full Text] [Related]
8. MRI study of subconjunctival and intravitreal injections.
Li SK; Hao J; Liu H; Lee JH
J Pharm Sci; 2012 Jul; 101(7):2353-63. PubMed ID: 22473517
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in ocular drug delivery.
Chen H
J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
[TBL] [Abstract][Full Text] [Related]
10. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis: a non-invasive ocular drug delivery.
Eljarrat-Binstock E; Domb AJ
J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
[TBL] [Abstract][Full Text] [Related]
12. Anterior eye segment drug delivery systems: current treatments and future challenges.
Molokhia SA; Thomas SC; Garff KJ; Mandell KJ; Wirostko BM
J Ocul Pharmacol Ther; 2013 Mar; 29(2):92-105. PubMed ID: 23485091
[TBL] [Abstract][Full Text] [Related]
13. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
[TBL] [Abstract][Full Text] [Related]
16. Advancements in ocular drug delivery.
Weiner AL; Gilger BC
Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
[TBL] [Abstract][Full Text] [Related]
17. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
18. Sustained transscleral drug delivery.
Barocas VH; Balachandran RK
Expert Opin Drug Deliv; 2008 Jan; 5(1):1-10. PubMed ID: 18095925
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
20. Intraocular implants for extended drug delivery: therapeutic applications.
Bourges JL; Bloquel C; Thomas A; Froussart F; Bochot A; Azan F; Gurny R; BenEzra D; Behar-Cohen F
Adv Drug Deliv Rev; 2006 Nov; 58(11):1182-202. PubMed ID: 17107737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
